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GENERAL INTRODUCTION 
Cryptosporidium is a significant cause of diarrhea in both industrialized and 
developing countries (Ungar et al., 1990). Young children and immunocompromised 
patients usually have higher prevalence, in particular, those with acquired 
immunodeficiency syndrome (AIDS), with an incidence of about 10% (Laughon et al. , 
1991). Acute self-limiting diarrhea is the most common expression of infection in 
immunocompetent patients, whereas in immunocompromised patients, the disease can be 
prolonged and life-threatening (Fayer et al., 1986; Meisel et al., 1976). Waterborne 
outbreaks such as occurred in Milwaukee, Wisconsin, in April 1993, involving an 
estimated 370,000 individuals indicate the epidemic potential of this parasitic infection 
(Terry, 1993). A recent National Institutes of Health panel concluded that 
Cryptosporidium may now be one of the three most important enteropathogens causing 
diarrheal illness worldwide (Laughon et al. , 1991 ). 
Unfortunately, there is no anticryptosporidial therapy presently effective although 
over 150 drugs have been employed empirically in attempts to treat clinical or 
experimental infections (Reinemeyer, 1994). It is unclear whether this resistance is due to 
the unique intracellular but extracytoplasrnic location of the parasite which limits drugs 
uptake or to unique metabolic processes of the organism. However, information on 
biochemical processes of the organism as potential targets for intervention action does not 
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exist. One of the factors that directs current biochemical research effort on protozoa is the 
availability of parasite material for study. For Cryptosporidium, it is the main limiting 
factor. Furthermore, there is an absence of satisfactory reproducible in vitro cultivation 
methods conducive to biochemical and physiological studies. 
This thesis reports efforts to address some of these problems. The objectives were 
to establish the intestinal explant culture technique as a model for in vitro culture of 
Cryptosporidium, to study metabolic processes of Cryptosporidium as potential targets for 
drug intervention, and to evaluate the efficacy of some potential anticryptosporidial agents 
on the suckling mouse experimental model of Cryptosporidium parvum infection. 
This thesis is presented as a general introduction, a review of literature, three 
separate studies, a general summary, a list of references and acknowledgements. Each of 
the three studies begins with an introduction, followed by materials and methods, results, 
and ends with discussion. 
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LITERATURE REVIEW 
History 
Cryptosporidium was first reported in 1907 by a well-known American 
parasitologist, Ernest Edward Tyzzer, when he found numerous tiny parasites within the 
gastric glands of a laboratory mouse. This protozoan parasite infected the gastric 
epithelium of laboratory mice used in Tyzzer' s research program. Thus, it was named 
Cryptosporidium muris (Tyzzer, 1907). Three years later, in 1910, Tyzzer described the 
same organism in much greater detail and recognized many of the life cycle stages. In 
1912, he identified and named a second species, Cryptosporidium parvum, which was 
found in the small intestine of laboratory mice. Once again he provided details of 
morphology and life cycle (Tyzzer, 1912). For over half a century after Tyzzer' s work, 
cryptosporidial infection was not regarded as economically or medically important. Up to 
the 1970s, there were only sporadic reports of infection in species such as snakes (Triffit, 
1925), turkeys (Slavin, 1955), and guinea pigs (Jervis et al., 1966). In general, this 
parasite was considered to be rare and of no pathogenic importance. The first cases of 
human cryptosporidiosis were reported in 1976 (Nime et al., 1976; Meisel et al., 1976), 
but subsequent reports were rare until several identification methods of oocyst stages in 
fecal samples were developed in the 1980s, which provided health care workers and 
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scientists with reliable techniques for noninvasive diagnosis. The severity of the infection 
in patients with acquired immune deficiency syndrome (AIDS) greatly stimulated research 
interest worldwide. Since then, extensive research has been conducted on the parasite and 
its disease effects. In the 1980s, over 900 papers were published (Laughon et al., 1991). 
During this period, the concept of cryptosporidiosis was transformed from that of a rare 
and largely asymptomatic infection to an important, widespread pathogen of enterocolitis 
and diarrhea in several animal species, including humans. 
Taxonomic Position and Life Cycle 
Taxonomy and host specificity 
Cryptosporidium is one of several genera of protozoa in the phylum Apicomplexa 
that is referred to as coccidia. A total of 21 species of Cryptosporidium have been named 
from fish, reptiles, birds, or other vertebrate hosts (Angus, 1983; Fayer et al., 1986). But 
recent reviews and cross-transmission studies place the distinctiveness of many of these 
species in doubt. Only 6 of the isolates, including the two originally described by Tyzzer, 
are now accepted as valid species. A study of bovine cryptosporidial oocysts has revealed 
two species among mammals: Cryptosporidium parvum, small in size and very common, 
and Cryptosporidium muris, with large oocysts and much less common (Upton et al., 
1985). On the basis of oocyst morphology, it is C. parvum, not C. muris, that is 
responsible for clinical illness in humans and other mammals. Cross-transmission studies 
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conducted by inoculating oocysts of Cryptosporidium obtained from animals of one 
species into animals of other species demonstrate a lack of host specificity for 
Cryptosporidium. Isolates from mammals are generally infective for other mammals, and 
the isolates from avians are generally infective for other avians (Fayer et al., 1986; 
O' Donoghue et al. , 1987). However, transmission between avians and mammals has 
yielded mixed results. Oocysts of C. parvum from mammals produced mild respiratory 
infection in chickens inoculated intratracheally, but was not infective when given orally 
(Lindsay et al., 1987). At present, it is preferable to name a particular parasite obtained 
from a mammalian host as an isolate rather than a strain due to the present uncertainties in 
the taxonomy of Cryptosporidium spp. (Current, 1989). 
Life cycle 
Cryptosporidium completes its life cycle on intestinal and respiratory surface 
epithelia of its host. The parasite is monoxenous which means only one host is involved in 
the life cycle. Its reproduction is characterized by an alternating asexual and sexual stage. 
Briefly, the life cycle of Cryptosporidium is initiated when oocysts are ingested and 
sporozoites are released from oocysts ( excystation) and invade host cells. In general, 
sporozoites parasitize the brush border of epithelial cells. They invade the apical portion of 
epithelial cells and establish themselves immediately beneath the host cell membranes, 
where the unique parasitophorous vacuoles are formed. This special parasitizing site is 
termed as intracellular but extracytoplasmic. Each intracellular stage of Cryptosporidium is 
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within a parasitophorous vacuole confined to the microvillous region of the host cell. After 
penetration, the sporozoite rounds up and differentiates into a spherical trophozoite with a 
prominent nucleus. Asexual multiplication referred to as merogony or schizogony results 
when this nucleus divides. Two morphologic types of meronts have been observed. As the 
meronts matures, each nucleus becomes incorporated into a merozoite, which can 
potentially invade adjacent host cell to form additional type I meront (recycling of type I 
meront) or to form type II meront. The merozoites from type II meronts are thought to 
initiate sexual multiplication (gametogony), in which micro- and macrogarnonts develop. 
After fertilization, the macrogarnont develops into an oocyst, which contains four 
sporozoites when sporogony is complete. Approximately 20% of the oocysts are 
surrounded only by a single unit membrane (thin-walled oocyst) and these have been 
implicated as the stage of autoinfection (Current et al., 1989). It has been suggested that 
thin-walled oocysts may undergo sporogony and excystation within the same host, 
releasing sporozoites, penetrating into the microvillous region of other epithelial cells and 
reinitiating the infection. Most oocysts (about 80%) form a thick, two-layered, 
environmentally resistant oocyst wall (thick-walled oocyst) and are discharged in the feces 
or excreted with respiratory or nasal secretion. It is the thick-walled oocyst that transmits 
the infection from one host to another. 
Historic background 
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Cryptosporidiosis in Humans 
The first case of human cryptosporidiosis was reported in 1976 in a 3-year-old boy 
from rural Tennessee (Nime et al. , 1976). Two months later the second human case in a 
39-year-old college administrator was described by Meisel and colleagues (Meisel et al., 
1976). Subsequently to these reports, only a few cases were reported until 1982, when 
five cases in homosexual men with AIDS were documented (Ma et al., 1982). A survey of 
cryptosporidiosis by stool examination conducted at Vincent's Hospital & Medical Center 
of New York from 1981 to 1984 indicated that the rate of cryptosporidiosis increased 
exponentially both in immunocomprornised and immunocompetent individuals (Ma et al., 
1987). By 1986, the Centers for Disease Control (CDC) reported 697 (3 .6%) of the first 
19, 187 AIDS patients were infected with Cryptosporidium (Ungar, 1990). 
Prevalence 
Cryptosporidium now has been generally accepted as an agent of diarrhea 
throughout the world. In most published surveys, Cryptosporidium was the most common 
parasite found, and was considered to be the most significant of all known 
enteropathogens causing diarrheal illness. Geographic surveys based on fecal examination 
for Cryptosporidium oocyst excretion revealed the distribution and mean prevalence of 
Cryptosporidium infection on various land areas. Human infection has been identified on 
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all six inhabited continents. In the more industrialized countries of Europe and North 
America, the prevalence is lower, generally between 1 and 3%. In contrast, mean 
prevalence from elsewhere in the world is between 4.9% in Asia and 10.4% in Africa 
(Ungar, 1990). The prevalence of cryptosporidiosis in children is significantly higher than 
that in adults although the age range for infection has been shown to be between 3 days to 
95 years of age (Holten-Anderson et al. , 1984). Most infections are reported for children 
under 2 years of age (Ungar, 1990). Infection are often seasonal, with a high prevalence 
during warmer and wetter months (Tzipori et al., 1983; Rahaman et al., 1984; Shahid et 
al., 1985; Montessori et al., 1985; Wolfson et al., 1985). 
Clinical aspects 
The clinical manifestations vary from one group of individuals to another and can 
range from subclinical to severe. Severity is mainly dependent on the age and immune 
status of the host and the intensity of exposure. Generally, young and immunologically 
immature individuals have a greater prevalence of infection and experience more severe 
illness than adults. In immunocompetent animals and human patients, the disease is non-
life threatening and self-limiting with symptoms lasting a few days to a few weeks. These 
patients recover spontaneously, whereas immunodeficient individuals may become 
chronically or terminally ill. The clinical picture is dominated by watery, cholera-like 
diarrhea, which resists all treatment (Anon, 1982; Andreani et al. , 1983; Pitlik et al ., 
1983). The very frequent defecation is accompanied by considerable loss of fluid and 
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electrolytes. It may contain mucus but rarely blood or leucocytes, and it is often associated 
with weight loss (Soave et al., 1984). Other less common clinical features include nausea 
and vomiting, abdominal pain and cramps, and low-grade fever ( <39°C) (Baxby et al., 
1984; Wright et al., 1984; Holley et al., 1986). In the immune deficient patient, 
Cryptosporidium infections are not always confined to the gastrointestinal tract. A variety 
of respiratory problems (Kocochis et al., 1984; Ma et al., 1984; Goodstein et al., 1989; 
Hinnant et al., 1989), cholecystitis (Pitlik et al. , 1983; Margulis et al. , 1986; Kahn et al., 
1987), hepatitis (Gross et al., 1986) or pancreatitis (Gross et al., 1986; Hawkins et al., 
1987) has been reported. 
Pathology · 
Although the parasites can colonize throughout the gastrointestinal tract on the 
mucosa of the stomach, duodenum, colon and rectum, the lesions are usually most severe 
in the distal jejunum and ileum (Meisel et al., 1976). Infections at extra-intestinal sites 
including the gallbladder (Pitlik et al., 1983; Margulis et al., 1986; Kazlow et al., 1986; 
Kahn et al., 1987), pancreatic duct (Gross et al., 1986; Hawkins et al., 1987; Hinnant et 
al., 1989; Kahn et al., 1987; Kocoshis et al., 1984), and respiratory tract (Forgacs et al., 
1983; Kocochis et al., 1984; Ma et al., 1984; Goodstein et al., 1989) have been described. 
Microscopic lesions are similar among almost all host species infected. Cryptosporidium is 
found at the rnicrovillus border of intestinal epithelial cells without penetration into the 
cytoplasm (intracellular but extracytoplasmic). Infected epithelial cells morphologically 
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change from tall columnar to short cylindrical or even to cuboid structure (Meisel et al. , 
1976). Scanning electron micrographs reveal rounded parasitic protrusions on the intestinal 
epithelial surface that disrupt the delicate microvilli (Heine et al., 1984). Reduced villus 
height combined with crypt hyperplasia have been reported in hwnans and several 
experimental models of C. parvum infection (Meisel et al., 1976; Soave et al., 1984; 
Isaacs et al., 1985; Heine et al., 1984; Fayer et al., 1986). Consistent with this 
morphological change, brush border enzyme levels are diminished in C. parvum infected 
intestinal epitheliwn (Guerrant et al., 1990; Gardner et al., 1994). 
Pathophysiology 
Little is known of the pathophysiology of cryptosporidiosis. The morphological 
changes and the diminished absorption of nutrients suggest that malabsorption plays a role 
in the pathophysiology of diarrhea resulting from C. parvum infection. However, the 
available data on the electrical resistance of infected epithelium are conflicting. In a 
porcine experimental model, the tissue electrical resistance increased despite the villus 
destruction observed (Argenzio et al., 1990). However, in another study, the electrical 
resistance of monolayers of the immortalized hwnan crypt epithelial cell line, T84, was 
reduced in the presence of C. parvum infection (Adams et al. , 1994). It is also puzzling 
that C. parvum infected rodents do not develop diarrhea even with obvious morphological 
changes of the intestinal mucosa. The host response to infection may also play a role in 
the pathophysilolgy of cryptosporidial diarrhea. In a porcine model of C. parvum, 
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prostaglandin-mediated inhibition of Na+ -c1· cotransport contributed to the diarrhea found 
in cryptosporidiosis (Argenzio et al., 1993). Glutamine stimulated prostaglandin-sensitive 
Na+-H+ exchange (Argenzio et al., 1994). 
A recent study indicated the presence of a heat-labile, calcium-dependent, 
reversible, and mucosally active factor in the stools of calves infected with C. parvum that 
rapidly stimulates a chloride-dependent increase in short-circuit current in human jejunum 
mounted in Ussing chambers in vitro. The chloride dependence of the short-circuit current 
observed suggests that active secretion of chloride (which could result in diarrhea) was 
stimulated by the factor present in the stools of infected calves. This enterotoxic activity 
was dose-dependent, saturable, and may be responsible for secretory diarrhea in humans 
(Guarino et al., 1994). However, the source of enterotoxin is not clear. Whether it is 
produced by Cryptosporidium itself, or synthesized by parasite-infected intestinal epithelial 
cells, or due to the stimulation of host's enteric or systemic immune system or enteric 
nervous system is not known. 
Diagnosis 
The earliest cases of Cryptosporidiosis in humans were diagnosed by identification 
of endogenous stages of C. parvum by microscopic examination of intestinal biopsy or 
necropsy specimens. In 1980, this invasive and time-consuming procedure was replaced by 
a variety of techniques of identifying oocysts in fecal specimens. Acid-fast staining is 
usually the method of choice for the clinical microbiology laboratory (Garcia et al. , 1983; 
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Ma et al., 1983). Negative staining (Current, 1983) and Sheather' s sugar flotation 
(Current, 1986) are also useful in the research laboratory. The use of serodiagnostic 
techniques for monitoring exposure to Cryptosporidium has thus far been limited to a few 
laboratories. Antibodies specific to Cryptosporidium in sera obtained from persons 
recovered from confirmed infection (Campbell et al., 1983) and from eight other species 
of animals (Tzipori et al., 1981) have been detected by indirect immunofluorescent 
antibody (IF A) techniques. Specific anti-Cryptosporidium IgG, IgA and/or IgM were also 
detected by an enzyme-linked immunosorbent assay (ELISA). Although useful for 
epiderniologic evaluation, serologic studies have no role in the diagnosis of acute illness 
(Ungar et al., 1986; Current et at., 1988). 
Cryptosporidiosis in Calves 
Historical perspective 
The first described case of bovine cryptosporidiosis in an 8-month-old heifer with 
chronic diarrhea appeared in 1971 (Panciera et al., 1971). The significance of this finding 
was not fully appreciated because the infection was accompanied by Sarcocystis infection. 
This report was soon followed by nwnerous reports of sporadic case in which similar 
infection was found. Co-infection with other enteropathogens, particularly rotavirus, 
coronav~rus, enterotoxigenic Escherichia coli, or C/ostridium perfringens was frequently 
observed (Pohlenz et al., 1978; Tzipori et al., 1982; Angus, 1983; Fayer et al., 1985; 
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Current, 1985). In 1980, field studies demonstrated that the parasite was capable of 
causing clinical diarrhea in calves in the absence of concurrent infection with common 
viral or bacterial agents. This established Cryptosporidium spp. as a primary entero-
pathogen of calves (Tzipori et al., 1980). 
Prevalence 
Infection is most common in calves less than a month old, with a peak incidence at 
approximately 2 weeks of age (Meuten et al., 1974; Pohlenz et al., 1978; Moon et al., 
1982). All the calves on a dairy farm may become infected. Subclinical infection has been 
confirmed in adult cattle. Beef cows, though not proven, may be potential sources of 
infection for their calves (Anderson, 1987). Most infection results from horizontal 
transmission among calves or from oocysts persisting in the environment. The most 
common source of infection for a calf is contact with infected penmates. Calves may serve 
as a reservoir host for transmitting cryptosporidiosis to other farm animals (Tzipori et al., 
1982). Although the economic impact of cryptosporidiosis has not been accurately 
estimated, the high morbidity, weight loss, growth retardation, and occasional mortality 
likely represent a significant loss to the cattle industry. 
Clinical features 
The most common clinical sign of cryptosporidiosis in calves is yellow, watery, 
malodorous diarrhea which is associated with profuse shedding of infective oocysts (106 to 
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107/g of feces) (Current, 1985). The duration of diarrhea is determined by various factors 
such as host susceptibility, intensity of exposure, and age at the time of infection. In most 
cases, the diarrhea lasts 2 to 14 days, accompanied by varying degree of dullness, 
anorexia, depression, fever and loss of weight (Tzipori et al., 1980; 1981; 1983; Heine et 
al., 1984). Diarrhea associated with cryptosporidiosis is usually self-limiting. Mortality is 
typically low unless the calf is concurrently infected with other enteric pathogens. 
Pathology 
Only two species of Cryptosporidium have been identified in ruminants. The 
intestinal species, C. parvum is the one which most commonly causes ruminant 
cryptosporidiosis. The abomasal species, C. muris, found in cattle in the west central U.S. 
in 1985 (Anderson, 1987), is not considered a major parasite at this time. Parasites and 
lesions are most commonly concentrated in the distal small intestine (Pohlenz et al., 1978; 
Person et al., 1982; Sanford et al., 1982; Anderson, 1984). Mild to moderate villous 
atrophy, villous fusion, and crypt hyperplasia are also commonly observed. Changes in the 
surface epithelium include metaplasia to a low columnar or cuboidal form, degeneration 
and sloughing of enterocytes, shortening and disruption of microvilli, and increased 
numbers of lysosomes in parasitized cells (Pohlenz et al., 1978). Microscopic lesions 
appear to be consistent whether or not other pathogens are present. 
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Diagnosis 
The demonstration of oocysts in the feces of diarrheic animals is indicative of 
infection. As with human cryptosporidiosis, sucrose flotation (Anderson, 1981 ), acid-fast 
(Ma et al. , 1983) and Giemsa staining (Pohenz et al. , 1978) are applied. Histologic or 
immunocytochemical examinations of freshly fixed and/or frozen intestinal tissue may 
identify agents undetected in fecal smears (Hall et al., 1988). 
Cryptosporidiosis in Lambs 
Historical perspective 
Ovine cryptosporidiosis was first diagnosed in Australia in 1974 in diarrheic lambs, 
1 to 3 weeks of age (Barker et al., 1974). Endogenous stages of Cryptosporidium were 
demonstrated by electron microscopy. Subsequently, several outbreaks of diarrhea in lambs 
associated with excretion of cryptosporidial oocysts were reported (Tzipori et al., 1981 ; 
Anderson, 1982). In transmission experiments, specific pathogen-free lambs developed 
severe diarrhea following oral administration of calf feces containing cryptosporidial 
oocysts (Tzipori et al. , 1981 ). Similar results were obtained when germ-free lambs were 
inoculated with calf cryptosporidial oocysts that were free of viruses and bacterial 
contaminants. These studies confirmed that Cryptosporidium was pathogenic for neonatal 
lambs (Snodgrass et al., 1984). 
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Clinical sign and lesion 
As in calves, the primary clinical sign is diarrhea, which is most severe if 
complicated by concurrent infection with other enteric pathogens. Numerous oocysts are 
excreted in diarrheic stools. Infected lambs are often depressed and anorexic. (Tzipori et 
al., 1981; Casemore et al. , 1985). Lesions may be found in the entire small intestine and 
much of the large intestine. Villous atrophy, villous fusion, absence of mucus-secreting 
cells and epithelial cross bridging between contiguous villi were frequently described 
(Tzipori et al., 1981 ; Angus, 1983). The infections were age-dependent with more severe 
infection in the newborn (Tzipori et al., 1981 ). The presence of oocysts in feces or gut 
contents can be diagnosed by examining Giemsa-stained smears. 
Cryptosporidiosis in Birds 
Historical background and prevalence 
Two species of Cryptosporidium have been confirmed in avian species. 
C. meleagridis was named by Slavin in 1955 when he found the parasite in the ileum of a 
turkey (Slavin, 1955), thirty three years after Tyzzer's first description (Tyzzer, 1929). In 
1986, Current and colleagues named C. baileyi to the species of Cryptosporidium isolated 
from broiler chickens (Current et al., 1986). 
Cryptosporidium infections of avain species have been reported in chickens 
(Dhillon et al., 1981 ; ltakura et al., 1984; Goodwin et al., 1988; Latimer et al., 1988; 
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Nakamura et al., 1988), turkeys (Hoerr et al., 1978; Glisson et al., 1984; Tarwid et al. , 
1985; Ranck et al., 1987), quails (Tham et al., 1982; O' Donoghue et al. , 1987), ducks 
(O' Donoghue et al. , 1987), geese (Porctor et al., 1974; Current et al., 1986), pheasants 
(Whittington et al., 1985; O' Donoghue et al., 1987), and peacocks (Mason et al. , 1980). 
However, information on the prevalence of infection in these avian species is scarce. 
Clinical feature and lesion 
Naturally occurring cryptosporidiosis in birds manifests itself in three clinical 
forms: respiratory disease, enteritis, or renal disease. Usually only one form is present in 
an outbreak, but combinations of the three have occurred (Nakamura et al., 1988). 
Concurrent bacterial infections were also observed. Studies conducted with C. baileyi 
revealed that the route of inoculation was the major factor that influenced the infectivity 
and site of development of the parasites in experimentally infected chickens (Lindsay et 
al., 1986; 1987). Little is known about the site specificity of C. meleagridis. Clinical 
respiratory signs consisting of coughing, sneezing, and dyspnea were associated with 
infection with this species. Hypertrophy and hyperplasia of the epithelial surface and loss 
of cilia of the tracheal epithelium are the common histological findings. Numerous 
cryptosporidia were found within the ciliated border of the tracheal epithelium, on the 
luminal surface of the mucous glands, and on the respiratory epithelium of nasal passages 
(Goodwin, 1989). Diarrhea is the major clinical sign in cryptosporidial enteritis in turkeys 
(Slavin, 1955; Goodwin et al., 1988; Wages et al., 1989). Gross lesions are confined to the 
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small intestine and occasionally the cecum. Intestinal distention due to mucoid intestinal 
contents and gas is commonly seen. Clinical signs of renal cryptosporidiosis are often 
masked by respiratory and/or gastrointestinal signs of the disease in chickens (Nakamura et 
al., 1988). The major microscopic findings include hyperplasia, hypertrophy of the 
epithelial cells and the presence of Cryptosporidium in collecting ducts, collecting tubules, 
and rarely in the distal convoluted tubules. 
Transmission of Cryptosporidium 
C. parvum infection is spread through fecal-oral contamination of oocysts, a fact 
confirmed by numerous transmission experiments. Cross-transmission studies discussed 
previously, demonstrated that C. parvum is not host specific. Isolates from humans are 
infectious for a variety of mammals, and isolates from one mammalian species are 
infectious for others (Fayer et al., 1986; O'Donoghue et al., 1987). In persons closely 
associated with animals, the most Cryptosporidium infections are a result of zoonotic 
transmission (Mann et al., 1986; Pohjola et al. , 1986; Rahaman et al ., 1984; Anderson et 
al., 1982). The high incidence of cryptosporidiosis in veterinary workers, farmers, animal 
handlers and caretakers has been well documented (Crawford et al. , 1988). Many reports 
implicate cattle or other domestic animals as sources of human infection. At least 20 cases 
of infected laboratory workers have been reported (Anderson et al., 1982; Anon, 1982; 
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Reese et al. , 1982; Blagburn et al., 1983; Current, 1983; Levine et al., 1988; Pohjola et 
al., 1986). 
Infections as a result of contamination of the environment have been 
increasingly recognized. In 1987, Cryptosporidium was conclusively recognized as an 
agent of human waterborne disease (Rose, 1988; Hayes et al., 1989). Contaminated 
water for drinking or swimming has been implicated as a source of cryptosporidial 
oocysts from clearly documented waterborne outbreaks. In 1984, Braun Station, a 
suburb of San Antonio, Texas, experienced two outbreaks of cryptosporidial 
gastroenteritis caused by sewer leakage into the community's well water (D' Antonio 
et al., 1985). An outbreak of cryptosporidiosis was recorded in Sheffield, England in 
1986. Cryptosporidial oocysts were identified first from affected people, and 
subsequently from the drinking water supplied from a common reservoir. Laboratory 
investigations confirmed that catties on a farm adjacent to the reservoir complex were 
a possible source of contamination (Rush et al., 1987). Two similar outbreaks have 
been reported in Ayshire, Scotland, and Oxfordshire-Swindon, England in 1988 and 
1989, respectively (Anon, 1989; Milne, 1989; Smith et al., 1990). Consumption of 
untreated surface water appeared to be the primary risk factor linked to the outbreaks 
of cryptosporidial illness in 1986 in a day care center in New Mexico (Gallaher et al., 
1989). In January 1987, an estimated 13,000 case of gastroenteritis associated with a 
waterborne outbreak of cryptosporidiosis occurred among 64,900 residents of Carroll 
County, Georgia (Hayes et al., 1989). The latest waterborne outbreaks occurred in 
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Milwaukee, Wisconsin, in April 1993, involved an estimated 370,000 individuals 
(Terry, 1993). 
Person-to-person transmission has been documented in day-care centers, 
households and hospitals (Crawford et al., 1988). These reports suggested that close 
personal contact may be an important source of transmission. Thus, transmission can 
be either direct (by contact with an infected subject) or indirect (drinking water, food, 
bedding etc.). Airborne transmission is considered as a possible source of respiratory 
cryptosporidiosis in poultry (Dhillon et al., 1981 ; Hoerr et al. , 1978; Itakura et al., 
1984), but has not been documented in other species. 
Treatment and Prevention 
A total of over 150 agents have been tested for curative and preventive 
efficacy against cryptosporidiosis in humans or animals (Reinemeyer, 1994). These 
include antimicrobial agents, coccidiostats and other antiprotozoal compounds, and 
ionophorous. To date, no specific treatment has been found which consistently cures 
cryptosporidiosis. Only a few chemotherapeutic agents have shown any efficacy. 
Lasalocid, a polyether antibiotic which acts as an ionophore, was found to have dose-
dependent prophylactic effects in an immunosuppressed rat model (Rehg, 1993). 
Oocyst production of prednisolone-immunosuppressed mice was markedly reduced 
when lasalocid was administered prior to infection (Kimata et al., 1991). A 
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prophylactic effect of lasalocid against experimental C. parvum infection in calves 
was reported, but the required dosage was toxic (Moon et al. , 1982). Prophylactic 
administration of cyclosporin A, alborixin or maduramycin were effective in 
suppressing oocyst excretion in a suckling mouse model (Weikel et al., 1986). 
Spiramycin, a macrolide antibiotic, has been reported to provide symptomatic 
improvement in some patients with cryptosporidiosis (Portnoy et al., 1984; Connolly 
et al., 1988; Moskovitz et al., 1988), but not in others (Gross et al., 1986; Lazo et al., 
1986; Wittenberg et al., 1989). Arprinocid reduced the lever of C. parvum recovered 
from neonatal hamsters, but not from mice (Kim, 1987). 
At present, treatment of cryptosporidiosis is limited to supportive therapy with 
oral or intravenous hydration, parenteral nutrition, and treatment for concurrent 
infections. Supportive therapy is often required by both immunodeficient and 
immunocompetent patients, especially the young with severe cryptosporidial diarrhea. 
Immunocompetent individuals who have cryptosporidiosis respond well to supportive 
therapy. In contrast, immunocompromised patients are refractory to all treatments 
unless the cause of immunosuppression can be resolved or ameliorated. 
Since chemotherapy and chemoprophylaxis are ineffectual, the prevention of 
cryptosporidiosis has become more important. Cryptosporidium oocysts are widely 
distributed in the environment, particularly in water, but food or milk products may 
be potential sources (Ungar et al., 1990). The infective oocysts survive for long 
periods in the environment. As long as the thick, two-layered wall remains intact, the 
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oocysts are remarkably resistant to most common disinfectants and can survive for 
months if kept cold and moist (Tzipori, 1983; Sundermann et al., 1987). Hence, 
hygienic precautions must be taken to eliminate or reduce the infective source from 
the environment or avoid contact with known sources. 
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INTESTINAL EXPLANTS AS A MODEL FOR 
CRYPTOSPORIDIUM INFECTION 
Introduction 
Cryptosporidium parvum is a significant cause of diarrhea in animals and man. It 
causes moderate to severe diarrheal illness in immunocompetent individuals and life-
threatening disease in immunocompromised individuals (Fayer et al. , 1986; Meisel et al., 
1976). Cryptosporidiosis is also a frequent complication of humans with AIDS (Laughon 
et al., 1991 ). There are currently no effective drugs for the treatment of established 
infections of Cryptosporidium although over 150 drugs have been employed empirically 
in attempts to treat clinical or experimental infections (Reinemeyer, 1994). It is unclear 
whether this resistance is due to the unique intracellular but extracytoplasmic location of 
the parasite which limits drugs uptake or to unique metabolic processes of the organism. 
Studies of biochemical processes of the organisms as potential targets for drug action 
would be facilitated by an in vitro culture model. Although nearly 25 papers have been 
devoted to studying development of C. parvum in cell culture, there continues to be a 
need for a good, reproducible and practical in vitro model system. The intestinal mucosal 
explants developed by Nietfeld et al. (Nietfeld et al., 1990) may provide the basis for 
short-term culture of Cryptosporidium on ilea! epithelium and the means for rapid 
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screening of anti-infective drugs. However, the ability of Cryptosporidium to grow on 
these explants has not been evaluated. 
The objectives of this study were to establish the intestinal explant culture 
technique as a model for in vitro cultivation of Cryptosporidium and to develop a system 
for rapid pharmacological screening of anticryptosporidial drugs. 
Materials and Methods 
Culture medium 
RlvfPI 1640 medium with HEPES buffer and L-glut.amine, supplemented with 5% 
heat-inactivated fetal bovine serum (FBS), 0.25% lactalbumin hydrolysate, 0.2 µg of 
hydrocortisone/ml, and 0.1 µg of insulin/ml was used. Penicillin G (100 U/ml), 
streptomycin (100 µg/ml), amphotericin B (0.1 µg/rnl), and gentamicin (50 µg/ml) were 
added to the medium to inhibit bacterial and fungal growth. Ascorbic acid (0.3 mg/ml), 
sodium butyrate (I 0 mM), and propionic acid ( 10 mM) were also added to improve 
mucosa! preservation and cellular morphologic features. 
Preparation of explants 
Pigs intestinal explants 
Pigs, 1 to 4 days old, from SPF sows were used. A laparotomy was performed 
following anesthesia with halothane. A section of ileum was isolated and washed by 
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injection of 0.9% cold saline. The serosa and muscularis were removed and explants 
prepared as described (Nietfeld et al., 1990). After the ileal specimens were soaked for 
0.5 hours in cold 0.04% sodium hypochlorite solution to reduce microbiological 
contamination, they were cut into 2.5 cm long sections, and rinsed three times in cold 
RMPI 1640 medium (GIBCO Laboratories, Grand Island, NY). The sections were then 
opened along the mesenteric border and cut into 3 x 5 mm pieces. The ileal pieces were 
then placed villi uppermost on 1 x 1 cm gelfoam sponges (Upjohn CO, Kalamazoo, MI) 
presoaked with medium. Two explants were placed in each 60-mm plastic petri dish and 
3.0 ml cell culture medium was added. The medium just reached the base of the explants, 
and capillary action pulled the medium over the villus surface. The cultures were 
incubated on a rocking platform set at 6 cycles/min in an atmosphere of 5% C02 and 
95% air at 37°C. Medium was changed at 24 hours intervals. 
Mouse intestinal explants 
Mouse intestinal explants were prepared from CF-I suckling mice as described 
above. 
Preparation of inoculum 
Purified calf isolate of C. parvum oocysts were obtained from Dr. James A. Harp 
of the National Animal Disease Center (NADC). Excystation was initiated by 
preincubating oocysts in phosphate-buffered saline (PBS) for 1 hour at 37°C (Dubey et 
al., 1990). An equal volume of excystation fluid consisting of 1.5% sodium taurocholate 
-
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(w/v in PBS) with 0.5% trypsin (w/v in PBS) was added, and incubated for 45 minutes at 
3 7°C on a shaker. Sporozoites were washed free of excystation fluid by centrifugation 
twice at 1200 x g for 12 minutes in PBS. The pellet was then resuspended with PBS and 
adjusted to desired concentration. 
Infection and assessment 
Two methods were used to infect explants. For in vitro infection, intestinal 
explants were infected directly with excysted sporozoites by exposure of explants to 
culture medium containing 106 C. parvum sporozoites/dish. For preinfected explants, 
CF-1 suckling mice were inoculated orally with 10s C. parvum oocysts of calf origin at 6 
days of age. Sections of ileum were collected at peak infection, and ilea! explants 
prepared as above as flat explants on gelfoam sponges. Both in vitro infected and pre-
infected explants were removed at 0, 24, 48, 72, 96, and 120 hours of culture, fixed in 
10% buffered formalin, processed for direct immunofluorescence assay. 
Specimens were tested with Merifluor Cryptosporidium-Giardia direct 
immunofluorescence (DIF) assays (Meridian Diagnostics, Inc. Cincinnati, OH). Forrnalin-
fixed explants were dehydrated and embedded in paraffin blocks. The explants were then 
sectioned at 5 µm and placed on treated slide wells. One drop of detection reagent 
containing fluorescein isothiocyanate (FITC) labeled anti-Cryptosporidium and anti-
Giardia monoclonal antibodies were added to each well, followed by one drop of 
counterstain. The reagents were then mixed with an applicator stick. After a 30 min 
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incubation at room temperature, the slides were rinsed with wash buffer (PBS) to remove 
excess detection reagent and counterstain. A drop of mounting medium was added to each 
well. A coverslip was applied and the slides were examined by fluorescent microscopy 
(160x) . 
For quick assessment, mouse explant samples were fixed with 10% buffered 
formalin for 30 min at room temperature. A drop of intestinal tissue suspended in fixative 
was placed on a treated slide well, spread over the entire well, allowed to completely air 
dry (about 30 min) and subjected to DIF test procedure as described above. 
Drug screening 
Experimental explants were exposed to fresh medium containing experimental 
drugs (azithromycin or novobiocin) at a concentration of 10·3 M, beginning at 24 hours 
post-infection (Pl). Both experimental explants and infected but untreated explants were 
sampled every 24 hours for 5 days and processed for DIF assay. 
Results 
Morphologically, the epithelia of explant were well preserved and retained a 
normal microvillus border through 72 hours of culture (Figure 1, Figure 2). Although in 
most cases, between 96 and 120 hours of culture, a loss of villus architecture was evident, 
the explants still contained viable villus epithelium at 120 hours (Figure 3). It was 
Figure 1. 
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Pig ileum mucosal explant after 24 hours of incubation. Sections of ileum 
(3 x 5 mm) were placed on gelfoam sponges and incubated in RMPI 1640 
medium. The villus epithelia are intact and retain normal , tall, columnar 
morphologic features (H. & E. stain) (400x). 
Figure 2 . 
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Pig ileum mucosa! explant after 72 hours of incubation. Sections of ileum 
(3 x 5 mm) were placed on gelfoam sponges and incubated in RMPI 1640 
medium . The villus epithelia are intact and retain normal , tall , columnar 
morphologic features (H. & E. stain) (400x). 
Figure 3. 
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Pig ileum mucosa! explant after 120 hours of incubation. Sections of ileum 
(3 x 5 mm) were placed on gelfoam sponges and incubated in RMPI 1640 
medium. The villus epithelia are intact and retain normal , tall, columnar 
morphologic features (H. & E. stain) (400x). 
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apparent that both pig and mouse intestinal explants were susceptible to the in vitro 
infection of C. parvum by exposure to culture medium containing sporozoites. Infection 
on pig explants at 24 and 96 hours of culture (Figure 4, Figure 5), and infection on 
mouse explants at 48 and 72 hours of culture were confirmed by direct 
imrnunofluorescent test (Figure 6, Figure 7). Irnmunofluoresence was observed on 
explants though 120 hours of culture. C. parvum appeared round to slightly oval in shape, 
with a bright apple green color. 
In preinfected mouse intestinal explants, infections of Cryptosporidium were 
detected on all explants during the entire 120 hours of cultivation (Figure 8, Figure 9). 
However, the infective stages of the parasite in culture were not demonstrated by 
H. & E. staining. This may be due to the loss of villus architecture which obscures the 
diagnosis by conventional light microscopy. 
In infected but untreated mouse expl:mts, Cryptosporidium infections peaked at 48 
to 72 hours PI. When azithromycin or novobiocin was added to culture medium, neither 
of them eliminate the infection of Cryptosporidium on explants (Data not shown). 
Discussion 
By modification of culture techniques and using flat explants we have observed 
the establishment of Cryptosporidium infection on intestinal explants. 
Organ culture of intestinal explants provides a method for preserving normal 
Figure 4. 
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Fluorescent micrograph showing specificity of direct immunofluorescence 
test for antibodies to Cryptosporidium on in vitro infected pig intestinal 
explant after 24 hours of culture. Explants were infected by the addition of 
106 sporozoites to the culture medium. Cryptosporidium appears round to 
slightly oval in shape with a bright apple green color ( 160x). 
Figure 5. 
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Fluorescent micrograph showing specificity of direct immunofluorescence 
test for antibodies to Cryptosporidium on in vitro infected pig intestinal 
explant after 96 hours of culture. Explants were infected by the addition 
of 106 sporozoites to the culture medium. Cryptosporidium appears round to 
slightly oval in shape with a bright apple green color (160x). 
Figure 6. 
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Fluorescent micrograph showing specificity of direct immunofluorescence 
test for antibodies to Cryptosporidium on in vitro infected mouse intestinal 
explant after 48 hours of culture. Explants were infected by the addition of 
l 06 sporozoites to the culture medium. Cryptosporidium appears round to 
slightly oval in shape with a bright apple green color. Intestinal explants in 
formalin suspensions were used for the immunofluorescent detection of C. 
parvum (160x). 
Figure 7. 
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Fluorescent micrograph showing specificity of direct immunofluorescence 
test for antibodies to Cryptosporidium on in vitro infected mouse intestinal 
explant after 72 hours of culture. Explants were infected by the addition 
of 106 sporozoites to the culture medium. Cryptosporidium appears round 
to slightly oval in shape with a bright apple green color. Intestinal explants 
in formalin suspensions were used for the immunofluorescent detection of 
C. parvum (160x). 
Figure 8. 
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Fluorescent micrograph of C. parvum preinfected mouse intestinal 
explant after 48 hours of culture. Explants were prepared from CF-1 
suckling mice orally inoculated with 105 oocysts. Intestinal explants in 
formalin suspensions were used for the immunofluorescent detection of C. 
parvum (250x). 
Figure 9. 
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Fluorescent micrograph of C. parvum preinfected mouse intestinal 
explants after 96 hours of culture. Explants were prepared from CF- I 
suckling mice orally inoculated with 105 oocysts. Intestinal explants in 
formalin suspensions were used for the immunofluorescent detection of C. 
parvum (250x). 
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histologic structure and mucosal viability in vitro (Nietfeld et al., 1990). Explant cultures 
provide a solution to some of the disadvantages of other animal models of 
cryptosporidiosis. Large numbers of explants can be prepared from a single animal, thus 
greatly reducing the number of animals required for a given study. The testing 
environment can be precisely controlled, thus reducing the variables created by the 
presence of extra-intestinal secretions, normal intestinal flora, and possibly other 
copathogens. Furthermore, test materials can be easily added or withdrawn from the 
culture medium to study their effects on the mucosa. Explant methods also prevent the 
contamination of the environment from oocysts shed by infected animals. Also, the 
effects of several test materials can be tested on explants derived from the same animal, 
thus reducing individual variation. 
Cryptosporidium infection of explants can be easily detected by direct 
immunofluorescent antibody. The assay is simple to perform and has higher sensitivity 
than traditional staining procedures (Garcia et al., 1987), which make it useful as a 
detection method for quick pharmacological screening of anticryptosporidial agents on the 
intestinal explants. Although the architecture of villi cannot be demonstrated under the 
florescence microscope, intestinal epithelial cells of explants are visible. The commercial 
fluorescent kit was originally designed for detecting oocysts in fecal stools by direct 
monoclonal antibody reaction against the cell wall antigen of Cryptosporidium oocysts. 
The results of this study suggest that Cryptosporidium infection on intestinal specimens 
can be detected by monoclonal antibody. 
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Like other in vitro culture models, the extent of multiplication and the number of 
parasites produced on intestinal explants are much lower than in experimentally infected 
suckling mice or in chorioallantoic membranes of chicken embryos. The reduced 
proliferation in culture was attributed to the absence of the autoinfective oocysts that 
develop in the mouse intestine and in the chorioallantoic membranes of chicken embryos 
(Dubey et al, 1990). 
The highly controllable environment of the intestinal explants may be suited to the 
study of parasite-enterocyte interaction and for the development or evaluation of 
anticryptosporidial chemotherapeutic agents. Further studies will attempt to refine the 
model to include methods such as electron microscopy to confirm the presence of 
developmental stages of the parasite on explants and to quantify the mucosa! infection. 
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LACTATE PRODUCTION, AMYLOPECTIN CATABOLISM AND 
MANNITOL :tvffiASUREMENT IN CRYPTOSPORIDIUM 
Introduction 
Cryptosporidium infections are remarkably resistant to antiprotozoal drugs and 
there is currently no effective therapy for established infections (Reinemeyer, 1994). 
Information on metabolic processes of the organism which might be amenable to 
pharmacologic attack is lacking. One of the factors that limits current biochemical 
research on Cryptosporidium is the availability of satisfactory methods of cultivation of 
the organism in vitro. In addition to its role as the infective stage, the sporozoite is one of 
the few life cycle stages not associated with host cells. For this reason, the sporozoite 
may be a stage at which pharmacologic attack may yield clinically useful drugs. 
The objective of this study was to characterize selected metabolic processes in 
Cryptosporidium sporozoites as potential targets for drug intervention. Like other 
coccidia, amylopectin granules are stored in the developmental stages in Cryptosporidium 
and may serve as source of energy. However, there is no information on glycolytic rates 
in Cryptosporidium. In this study, lactate production and amylopectin catabolism in 
freshly prepared sporozoites were measured. A new metabolic pathway, known as the 
mannitol cycle, has been identified in the coccidian parasite Eimeria tenella (Schmatz et 
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al., 1989). It may be important for the production and utilization of energy reserves for 
the parasite. This pathway has not been found in any other animal system and was 
previously thought to be unique to fungi. The amount of mannitol in oocysts was 
measured in this study. 
Materials and Methods 
Preparation of sporozoites 
The excystation procedure was described on page 26. Viability assessment was 
made on excysted sporozoite samples placed on an indentation slide at 0, 30, 60, 90, and 
120 min following excystation. The nwnber of sporozoites was quantitated by using a 
phase hemacytometer. The infectivity of sporozoites was determined by intrarectum 
inoculation of suckling mice with I 05 C. parvum sporozoites. 
Measurement of sporozoite glycolysis 
Lactate production and intrasporozoite amylopectin concentration in 106 
sporozoites were determined at 0, 30, 60, 90, and 120 min following excystation and 
incubation at 37°C in glucose-free Hank's balanced salt solution (HBSS). For lactate 
assay, aliquots of sporozoite suspension were mixed with equal volwnes of 8% perchloric 
acid and quickly frozen at -80°C until assayed. Lactate concentration was determined by 
the increased absorbance at 340 nm due to NADH formation following oxidation of 
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lactate to pyruvate by lactate dehydrogenase (Sigma Chemical Co, St Louis, MO). For the 
amylopectin assay, half volumes of 0.6 N perchloric acid were used. Amylopectin 
concentration was measured as described by Keppler and Decker, 1974. Briefly, 
amylopectin was hydrolysed to glucose by amyloglucosidase. Enzymatic phosphorylation 
and dehydrogenation of liberated glucose to 6-phosphogluconolactone and NADPH 
resulted from the addition of hexokinase and glucose-6-phosphate dehydrogenase, 
respectively. NADPH was measured spectrophotometrically at 340 nm and was 
proportional to the glucose liberated from amylopectin (Keppler et al., 1974). 
Mannitol assay 
A 2 ml aliquot of oocyst suspension (107 oocysts/ml) was homogenized to break 
the cell walls. The suspension was then dried under a stream of nitrogen. The dried 
material was resuspended in 4 ml chloroform/methanol ( 1 : 1, v/v) and left overnight. The 
following day the samples were again dried under a stream of nitrogen gas, resuspended 
in 0.5 ml distilled water, centrifuged at 12000 x g for 5 min to remove particulates, and 
the supernatant passed over a C18 Sep-Pak filter (Waters Associates, Milford, MA) in 
water to remove lipids. Ethanol was added to the eluent to a final concentration of 80% 
(v/v). The precipitate was removed by microcentrifugation and the supernatant containing 
the polyols was dried under nitrogen. Acetic anhydride (200 µl) and pyridine (200 µl) 
were then added, left overnight and dried under nitrogen gas. Methylene chloride (100 µl) 
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was added before analyzing on a gas chromatograph (GC). Acetate-derivatived samples 
were analyzed on Bendix GC (series 2300) fitted with a packed column (1.5 m x 4 mm 
i. d., 4% SE 30, 6% OV 210, chromosorb-W-HP) (Alltech Associates Inc, Deefield, IL) 
and a flame ionization detector (FID). The column temperature was 240°C, and the 
detector temperature was 250°C. Concentrations of mannitol were determined by 
comparison of peak areas to standard curves of the mannitol standards (Schmaltz et al., 
1988). 
Results 
The infectivity and the viability assessment on sporozoites revealed that 
sporozoites were infective to suckling mice and their motility was maintained during the 
incubation. 
Lactate production and amylopectin concentrations of 106 sporozoites incubated in 
glucose-free HBSS at 37°C are shown in Figure 10 and Figure 11. The data are expressed 
as percentage of zero-time controls to standardize between trials. Lactate concentration 
increased slightly only at 90 and 120 min following excystation. In some of the trials 
(2 out of 5), the concentration remained the same during the whole incubation period. 
There were no significant changes in amylopectin concentrations in sporozoites at 30, 60, 
90, or 120 min of incubation (Figure 11 ). In some experiments, 105 or 107 sporozoites 
were incubated for 4 hours with similar results (data not shown). 
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Lactate production by C. parvum sporozoites (106) incubated in glucose-
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experiments. Data are expressed as the percentage of zero-time controls. 
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No mannitol could be detected in oocyst preparations. The sensitivity limit of the 
method was 0.014 mM. 
Discussion 
Glucose as a source of energy is essential to the survivability of protozoa. 
Amylopectin is a branched polysaccharide found as granules in almost all stages of the 
life cycle of coccidian parasite E. tenella. Metabolic studies on extracellular E. tenel/a 
sporozoites revealed a linear increase in lactate production during a two hour incubation 
in a glucose-free medium. Amylopectin concentration in E. tenella sporozoites decreased 
by 50% over the same time period indicating a high rate of glycolysis (Smith et al., 
1983). For a long time, amylopectin was thought to be the parasite's only carbohydrate 
reserve (Ryley et al., 1969). However, the consumed amylopectin during the early stages 
of sporulation may be followed by resynthesis of the same polysaccharide prior to 
completion of the process (Wilson et al., 1961). Recent studies with E. tenel/a have now 
identified mannitol as accounting for 25% of the oocyst dry weight. Mannitol is present 
at very high concentrations in the unsporulated oocyst, approaching levels as high as 300 
mM. After sporulation is complete, the concentration of mannitol falls to approximately 
10 mM suggesting that it is being used as energy source (Schmatz et al., 1988). A similar 
mannitol cycle as that found in fungi has now been identified in E. tenella. All of the 
required enzymes have been found in both sporulated and unsporulated oocyst and 
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mannitol-1-phosphatase (MlPase) has been found in Eimeria sporozoites (Schmatz et al., 
1989). Two of the enzymes in the mannitol cycle, mannitol-1 -phosphate dehydrogenase 
(MlPDH) and mannitol-1-phosphatase (MlPase) were also found in C. parvum (Schmatz 
et al., 1989). However, in our study, mannitol was not detected in oocysts and the 
presence of the mannitol cycle in C. parvum could not be confirmed. This may due to the 
lack of sensitivity of the method or to the fact that, unlike other true coccidia (e.g., 
Eimeria and lsospora spp.), C. parvum oocysts undergo sporogony while they are within 
the host cells. Mannitol may be used up during sporulation so very low levels of mannitol 
would be present in oocysts released in feces. 
Large amounts of amylopectin granules have also been found in the developmental 
stages of Cryptosporidium by transmission electron microscopy (TEM) (Dubey et al., 
1990). Amylopectin may provide an energy source for developmental stages of parasite in 
vivo. However, in present study the glycolysis pattern of E. tenella was not found in C. 
parvum sporozoites incubated in HBSS at 37°C. Lactate concentrations did not 
significantly increase with time. There was no decrease in amyloglucosidase release of 
glucose in excysted sporozoites for up to 4 hours. The results suggest that amylopectin 
may not be the major source of energy for Cryptosporidium sporozoites. This may also 
explain why antibiotics such as nojirimycin and deoxynojirimycin which specifically 
inhibit glucosidase I and II (enzymes necessary for the breakdown of glycogen and 
amylopectin) are not effective for Cryptosporidium infection. It is also possible, although 
unlikely, that Cryptosporidium resynthesize amylopectin while they are using it as an 
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energy source. Further studies are required to determine the metabolic energy source for 
Cryptosporidium. 
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EFFECTS OF POTENTIAL ANTICRYPTOSPORIDIAL AGENTS ON 
CRYPTOSPORIDIUM INFECTIONS OF SUCKLING MJCE 
Introduction 
Cryptosporidiosis, an enteric disease of humans and animals caused by the 
protozoan Cryptosporidium, occurs worldwide (Ungar, 1990). The disease may be fatal in 
immunocompromised individuals, and is a frequent complication of humans with AIDS 
(Laughon et al., 1991). Data regarding the diagnoses, clinical signs and epidemiology of 
the disease are well documented, but no effective chemotherapy or immunotherapy is 
available (Casey, 1991). With the eYl;Janding epidemic of AIDS, there is a critical need 
for effective anticryptosporidial therapy. 
In this study, several potential anticryptosporidial agents were screened on the 
suckling mouse experimental model of C. parvum infection. 
Materials and Methods 
Infection of mice 
Groups of 7 to 11 CF-I suckling mice were housed with their dams in sterilized 
cages. Mice were inoculated orally with 105 purified C. parvum oocysts of calf origin 
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(courtesy of Dr. James A. Harp, National Animal Disease Center, Ames, IA) at 6 days of 
age. 
Medication 
Potential therapeutic agents including novobiocin ( 4 mg/ml), a DNA gyrase 
inhibitor; nojirimycin (4 mg/ml), a glucosidase inhibitor; and griseofulvin (5 mg/ml), a 
fungistatic antibiotic which inhibits spindle formation in mitosis; azithromycin (20 
mg/ml), a macrolide antibiotic; were administered. Medication was started at 8 days of 
age (48 hours-post infection) and given daily by gavage (0.05 ml per mouse) in 
experimental groups during the entire experimental period. 
Assessment 
Mice were sacrificed at 24 hour intervals. Portions of ileum (5 mm) were 
immediately fixed in 10% buffered formalin and processed for histologic evaluation. 
Hematoxylin-eosin (H. & E.) stained sections of the distal ileum were examined 
microscopically at 400x under bright field illumination. Infections of Cryptosporidium 
were scored as 1 + to 4+ according to the scale: < 5/field = 1 +; 5 to 25/field = 2+; 25 to 
50/field = 3+; > 50/field = 4+. The mean infection scores of experimental groups were 
compared with that of the infected but untreated groups. 
In some experiments, fecal smears and mucosa smears of ileum were prepared and 
examined for oocysts by acid-fast staining. 
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Results 
Uninoculated mice remained negative for Cryptosporidium throughout the 
experiment. 
Using H. & E. stain, C. parvum appeared nearly round with a pink color, and 
were confined within the microvillus border of infected villus epithelial cells (Figure 12). 
The score of infections was averaged among trials both in experimental groups 
and infected but untreated groups and plotted over time (hours post-infection). 
Cryptosporidium infections appeared as early as 72 hours post-infection (PI), with peak 
infections at 96 to 144 hours PI in infected but untreated groups (Figure 13). The severity 
of infection correlated well with the degree of fecal shedding. 
No anticryptosporidial activity was found in suckling mice treated with 
novobiocin (50 mg/kg/day), nojirimycin (50 mg/kg/day) or griseofulvin 
( 100 mg/kg/day). None of them diminished the degree or duration of infection (Figure 14, 
Figure 15, Figure 16). However, novobiocin and griseofulvin slightly delayed the onset of 
infection. 
Only light infections ( + 1) were detected at 144 and 168 hours PI (Figure 17) in 
azithromycin (400 mg/kg/day) treated mice, which was significant lower than untreated 
mice or mice treated with other three drugs (P < 0.01 ). 
Figure 12. 
52 
Histologic section of ileum from mouse orally infected with 105 C. parvum 
oocysts. Note the numerous parasites with different sizes within the brush 
border of the enterocytes (H. & E. stain) (x400). 
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96 to 144 hours post-infection. 
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Effect of novobiocin (50 mg/kg/day) on experimental C. parvum infection 
of suck.ling mice. Mice were infected orally with I 05 oocysts at 6 days of 
age. Medication was started at 8 day of age and given daily by gavage. 
Results are the means of 3 mice at each time period. Infection scale is the 
same as described in Figure 13. 
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Effect of nojirirnycin (50 mg/kg/day) on experimental C. parvum 
infection of suckling mice. Mice were infected orally with 105 oocysts at 6 
days of age. Medication was started at 8 days of age and given daily by 
gavage. Results are the means of 3 mice at each time period. Infection 
scale is the same as described in Figure 13. 
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Effect of griseofulvin (100 mg/kg/day) on experimental C. parvum 
infection of suckling mice. Mice were infected orally with 1 os oocysts at 6 
days of age. Medication was started at 8 days of age and given daily by 
gavage. Results are the means of 3 mice at each time period. Infection 
scale is the same as described in Figure 13. 
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Effect of azithromycin (400 mg/kg/day) on experimental C. parvum 
infection of suckling mice. Mice were infected orally with 105 oocysts at 6 
days of age. Medication was started at 8 days of age and given daily by 
gavage. Results are the means of 3 mice at each time period. Infection 
scale is the same as described in Figure 13. 
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Discussion 
The rationale for selection of these agents was based on their mechanism of 
action and the absence of previous studies (novobiocin, nojirimycin, griseofulvin) or 
reported efficacy in other models of cryptosporidiosis (azithromycin). Novobiocin inhibits 
the beta subunit of DNA gyrase to block supercoiling and chain formation in bacteria and 
thus prevents replication. Nojirimycin inhibits glucosidase thus prevents the breakdown of 
amylopectin to glucose (Romero et al ., 1985). If amylopectin serves as an energy source 
for the organism, this antibiotic might inhibit growth. Griseofulvin is an antifungal 
antibiotic which binds to microtubules and inhibits mitotic spindle formation in fungal 
hyphae. Its action is similar to that of colchicine which inhibits mitosis in mammalian 
cells, but is too toxic for therapeutic use. Colchicine inhibited C. parvum infectivity in a 
human enterocyte cell culture (Wiest et al., 1993). Azithromycin suppressed 
Cryptosporodium oocyst shedding in immunosuppressed adult mice (Kimata et al. , 1991). 
The mechanism of action of azithromycin in bacteria is inhibition of protein synthesis, 
but the mechanism of its action on protozoa is unknown. 
Anti-cryptosporidial activity was only found in azithromycin-treated suckling 
mice. None of the drugs tested in this study totally suppressed Cryptosporidium infection. 
Nojirimycin is a glucosidase inhibitor thus prevents the breakdown of 
amylopectin. In an earlier phase of our study, amylopectin concentration in sporozoites 
did not decrease with time up to 4 hours following excystation, which indicated that 
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amylopectin may not be the only energy source. This may explain the lack of 
effectiveness of nojirimycin against Cryptosporidium. 
No anticryptosporidial activity was observed when using novobiocin and 
griseofulvin, expect for a slight delay (24 hours) of onset of infection. 
Azithromycin showed marked anticryptosporidial activity, but did not eliminate 
infection completely even at a dosage ( 400 mg/kg/day) which was toxic to one-third of 
the mice. Similar results were observed with an immunosuppressed rat model, in which 
cryptosporidial infection was completely prevented by treatment with 200 mg/kg/day 
azithromycin for 9 to 10 days, but withdrawal of the drug after treatment was associated 
with recurrence of infection (Rehg, 1990). In prednisolone-immunosuppressed mice 
treated with azithromycin starting at 13 hours PI, the number of oocysts discharged was 
less than 1/100 of the control mice on 4 to 12 days PI (Kimata et al, 1991 ). 
To date, no specific treatment for cryptosporidiosis has been found although over 
150 agents have been tested (Reinemeyer, 1994). It is likely that any developments in this 
field will be made with drugs with novel mechanisms of action rather than with any 
existing antiprotozoal agents. 
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GENERAL SUMMARY 
To date, no effective treatment for cryptosporidiosis has been reported although 
more than 150 agents have been tested (Reinemeyer, 1994). Experimental work has been 
hampered by a lack of information on biochemical processes of the organism as potential 
targets for drug intervention and the absence of satisfactory in vitro cultivation methods. 
This thesis reports efforts to address some of these problems. 
Flat explant culture techniques were used in an attempt to grow C. parvum on pig 
and mouse intestinal mucosal explants. Two methods were used to infect explants. 
Cryptosporidium infections on both in vitro infected and pre-infected explants during the 
entire 120 hours of culture were demonstrated by direct immunofluorescent antibody. It is 
apparent that both pig and mouse explants were susceptible to in vitro infection of 
Cryptosporidium by exposure of explants to culture medium containing sporozoites. The 
DIF assay is simple to perform and has higher sensitivity than traditional staining 
procedures (Garcia et al., 1987), which make it useful as a detection method for 
Cryptosporidium infection. This culture model may provide a system for rapid 
pharmacological screening of anticryptosporidial drugs. However, the extent of 
multiplication and the number of parasites produced on intestinal explants are much lower 
than in experimentally infected mice or in chicken embryos. Further studies will attempt 
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to refine the model to include methods such as electron microscopy to confirm the 
presence of developmental stages of the parasite on explants and to quantify the mucosal 
infection. Several biochemical processes of C. parvum were investigated as potential 
targets for drug intervention. A similar mannitol cycle as that found in fungi has been 
recently identified in E. tenella. Two of the enzymes in mannitol cycle, MIPDH and 
MIPase were also found in C. parvum. However, in our study no mannitol was detected 
in oocyst preparation and the presence of the mannitol cycle in C. parvum could not be 
confirmed. This may due to the lack of sensitivity of the method or to the fact that, 
unlike other coccidia (e.g., Eimeria and lsospora spp.), C. parvum oocysts undergo 
sporogony while they are within the host cells. Mannitol may be used up during 
sporulation so very low levels of mannitol would be present in oocyst excreted from 
feces. Like Eimeria, Large amounts of amylopectin granules have also been found in 
developmental stages of Cryptosporidium by transmission electron microscopy (Dubey et 
al., 1990). However, the glycolysis patten of E. tenella was not found in C. parvum 
sporozoites incubated in glucose-free HBSS at 37°C. Lactate concentrations did not 
significantly increase with time. There was no decrease in amyloglucosidase release of 
glucose in excysted sporozoites for up to 4 hours. This results suggest that amylopectin 
may not be the major source of energy for Cryptosporidium. Further studies are required 
to determine the metabolic energy source for Cryptosporidium. 
The efficacy of potential anticryptosporidial drugs on Cryptosporidium infection of 
suckling mice was evaluated in the third phase of the study. No anticryptosporidial 
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activity was found in suck.ling mice treated with novobiocin (50 mg/kg/day), nojirimycin 
(50 mg/kg/day) or griseofulvin (100 mg/kg/day). None of them diminished the degree or 
duration of infection. Only light infections ( + 1) were detected at 144 and 168 hours post-
infection in mice treated with azithromycin ( 400 mg/kg/day), which was significantly 
lower than untreated mice or mice treated with other three drugs. Although a marked 
reduction of infection was observed in azithromycin treated mice, there was no complete 
elimination of Cryptosporidium infection. The efficacy of azithromycin confirms results 
obtained in other studies. It is likely that any developments in this field will be made with 
drugs with novel mechanisms of action rather than with any existing antiprotozoal agents. 
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